Clinical Trials Logo
  1. Home
  2. Cardiac Transplantation
  3. NCT02255123

Retrospective Multicenter Study to Determine 4-Year Clinical Outcomes in Subjects Previously Enrolled in the CTOT-05 Study

Cardiac Transplantation Clinical Trial

Official title:
A Retrospective Multicenter Study to Determine 4-Year Clinical Outcomes in Subjects Previously Enrolled in the CTOT-05 Study (CTOT-18)

Clinical Trial Summary

This study is a multicenter, non-randomized, retrospective study to collect long term (4 years post-transplant) clinical outcome data on subjects previously enrolled in the CTOT-05 study (NCT00466804) to evaluate participant and graft survival.

Clinical Trial Description

n/a

Study Design

Observational Model: Case-Only, Time Perspective: Retrospective

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02255123
Study type Observational
Source National Institute of Allergy and Infectious Diseases (NIAID)
Contact
Status Completed
Phase N/A
Start date October 2014
Completion date June 2015
View Details
See also
  Status Clinical Trial Phase
Completed NCT02672683 - Non Invasive Detection of Cardiac Allograft Rejection by Circulating microRNAs
Completed NCT01017029 - Everolimus in de Novo Heart Transplant Recipients Phase 4
Terminated NCT00338455 - Natrecor (Nesiritide) in Transplant-Eligible Management of Congestive Heart Failure-TMAC Phase 2
Completed NCT00170794 - Renal Safety of Everolimus in Addition to Cyclosporine Microemulsion in Cardiac Transplant Recipients. Phase 3
Completed NCT00000412 - Osteoporosis Prevention After Heart Transplant Phase 3
Completed NCT00716573 - Efficacy Study of Everolimus on Renal Function in Heart Transplant Recipients With Established Chronic Renal Failure Phase 4
Active, not recruiting NCT00799188 - CERTICOEUR: A Secondary Prevention Study of Skin Cancers in Heart Transplant Patients. Everolimus Versus Calcineurin Inhibitors Multicenter Trial Phase 3
Terminated NCT00284531 - Use of Daclizumab for the Prevention of Allograft Rejection in Pediatric Heart Transplant Patients Phase 1/Phase 2
Active, not recruiting NCT05904678 - Anatomical and Functional Assessment of Ex-vivo Coronary Perfusion
Terminated NCT01235910 - Clinical Pharmacology of Aliskiren in Combination With Cyclosporine in Cardiac Transplantation Phase 4
Active, not recruiting NCT00581321 - Oral Water Ingestion in Heart Transplant Patients N/A
Terminated NCT00166153 - Outcomes in Pediatric Heart Transplant Recipients Receiving Cellcept N/A
Completed NCT00414895 - Absolute Myocardial Perfusion Measurement in the Transplanted Heart N/A
Completed NCT03145441 - Intraoperative Use of Extracorporeal Cytokine Adsorption During Orthotopic Heart Transplantation N/A